| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.0093 | 0.8 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | ZSTK474 | GDSC1000 | pan-cancer | AAC | -0.009 | 0.8 |
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | -0.0095 | 0.8 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |